Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Think NoHep this World Hepatitis Day

Posted on by Dr. John W. Ward, Director, Division of Viral Hepatitis

Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E – affects hundreds of millions of people worldwide, causing acute and chronic liver disease and killing more than 1.4 million people every year, mostly from hepatitis B and hepatitis C. It is estimated that only 5% of people with chronic hepatitis know of their infection, and less that 1% have access to treatment.” – World Health Organization

Dr. John W. Ward, Director, Division of Viral Hepatitis
Dr. John W. Ward, Director, Division of Viral Hepatitis

CDC’s vision is to eliminate viral hepatitis in the United States and worldwide.  World Hepatitis Day – July 28, 2016 – is an opportunity to highlight the global burden of disease and our efforts to combat viral hepatitis around the world.

Viral hepatitis is the seventh leading cause of death worldwide, and causes more deaths than AIDS, tuberculosis, and even road injuries. After years of inattention, the substantial  global burden of viral hepatitis is beginning to receive much needed attention.  In May of this year, the first Global Health Sector Strategy on viral hepatitis of the World Health Organization  was approved during the 69th World Health Assembly.

This new WHO strategy introduces the first-ever global targets for the elimination of Hepatitis B and Hepatitis C as public health threats. These targets include a 30% reduction in new cases of hepatitis B and hepatitis C, and a 10% reduction in mortality by 2020, and ultimately achieving even greater health impact by 2030.  Key approaches to achieving these targets include:

  • expanding vaccination programs for hepatitis B;
  • preventing mother-to-child transmission of hepatitis B;
  • improving injection, blood, and surgical safety;
  • providing harm reduction services for people who inject drugs; and
  • increasing access to diagnosis and treatment for hepatitis B and hepatitis C.

Many of these approaches are included in CDC’s five-year strategic plan for 2016-2020.  The Strategic Plan is organized around four strategic imperatives, one of which is specific to our international efforts – “Act globally to prevent, detect, and control viral hepatitis.”

As of April 4, 2016, CDC has been redesignated as a Pan American Health Organization/World Health Organization (PAHO/WHO) Collaborating Center for Reference and Research on Viral Hepatitis.  In this capacity, CDC will support implementation of WHO Global Hepatitis Strategy priority activities, working to achieve WHO global hepatitis goals, serve as a reference of laboratory to support priority requests of the WHO Global Hepatitis Program, and provide technical assistance for the development of WHO normative guidance such as viral hepatitis guidelines and policies.

A cornerstone of CDC’s global activities is the the assignment of CDC staff to WHO headquarters to lead the WHO Global Hepatitis Program. This program  provides guidance and technical assistance to viral hepatitis control programs at the global, regional, and national levels. CDC’s global work also involves lending technical assistance to governmental and non-governmental entities as they develop hepatitis-related prevention policies and programs, respond to outbreaks, develop viral hepatitis surveillance, and monitor and evaluate these activities. For these efforts, CDC works with country-specific and global counterparts and partners, including local Ministries of Health and/or National Centers for Disease Control, other U.S. CDC programs, the United States Agency for International Development, the United States Department of State, and the World Health Organization (WHO).

In recent years, CDC has responded to requests for assistance from countries experiencing a high burden of viral hepatitis, including China, Egypt, Georgia, India, Pakistan, and Vietnam. This CDC programmatic assistance to other countries can reduce the burden of disease for travelers and among persons migrating to the United States while identifying best practices in viral hepatitis prevention and control that can serve as models for other countries including the United States. CDC is committed to continue working toward the elimination of viral hepatitis, both domestically and abroad.  The viral hepatitis epidemic has detrimental impact on lives, communities, and health systems around the world.  CDC and our global health partners need to act now in order to to make the elimination of viral hepatitis our next greatest achievement.

To learn more about viral hepatitis, please visit the CDC Viral Hepatitis website.

Posted on by Dr. John W. Ward, Director, Division of Viral HepatitisTags , , ,

2 comments on “Think NoHep this World Hepatitis Day”

Comments listed below are posted by individuals not associated with CDC, unless otherwise stated. These comments do not represent the official views of CDC, and CDC does not guarantee that any information posted by individuals on this site is correct, and disclaims any liability for any loss or damage resulting from reliance on any such information. Read more about our comment policy ».

    Dear Dr Ward Yes indeed! So many goals have been achieved in such a short period of time. From Hepatitis Day celebration Events at the Humphrey Building on May 19 to the adoption of the Global Health Sector Strategic plan on viral hepatitis your engagement and in hepatitis control has been restless. This victory and increasing attention on Hepatitis remind me efforts of so many others wonderful persons like Dr Jay Hoofnagle, Miss Joan and Dr Block, Dr McMahon, Dr Samuel So, Dr Elizabeth May, Dr Mark K Li, my dear friends Martha Saly, Peggy Farley, Jane Pan, Corinna Dan, Jeffrey Caballero and Mody Sissoko from Malian Association of DC and many more. Thanks you dear professor for the draft of the Global Strategic plan, Guidelines for the prevention care and treatment of persons with chronic Hepatitis B infection; Guidelines for the screening, care and treatment of persons with Hepatitis C infection, Guidelines for the Prevention of Hepatitis B transmission from Mother to Child, Guidelines for hepatitis monitoring and evaluation etc..
    With your great expertise in HIV and Hepatitis control I strongly hope CDC and Mali cooperation extends to reinforce Hepatitis control in Mali. Yes I think NO HEP this World Hepatitis Day. Dr Alioune B COULIBALY President APSAD/MALI drcoul@gmail.com

    This is great information! Providing information about how to lower and even eliminate Hepatitis B infections is the key to getting people on board. I urge everyone to consider getting themselves and their children vaccinated in an effort to help stop this preventable disease. In addition, people should educate themselves about the other types of Hepatitis that plague the world so that they can become safer, healthier people. http://liverandpancreassurgeon.com/hepatitis-a-b-and-c-what-you-need-to-know/

Post a Comment

Your email address will not be published. Required fields are marked *

All comments posted become a part of the public domain, and users are responsible for their comments. This is a moderated site and your comments will be reviewed before they are posted. Read more about our comment policy »

TOP